Essential workers illustrate the Heart of the Hutch
While buildings remain more than half empty, hundreds of people keep science going and campus running amid pandemic Isma Lubega stands in front of his car in Kampala, Uganda. Lubega is the driver for the UCI-Fred Hutch Collaboration, a program born out of a longstanding relationship between Fred Hutch’s Global Oncology program and the Uganda Cancer Institute. Photo courtesy of Raquel Sanchez / Fred Hutch Global Oncology
Heart of the Hutch: Essential Worker edition
We have been profiling people who illustrate the culture and spirit of Fred Hutchinson Cancer Research Center with the Heart of the Hutch series. This edition focuses on the essential workers.
Moderna COVID-19 vaccine poised for US greenlight after FDA advisory panel endorsement
abc11.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abc11.com Daily Mail and Mail on Sunday newspapers.
What to Expect as Moderna s Coronavirus Vaccine Rolls Out in Washington State
chronline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chronline.com Daily Mail and Mail on Sunday newspapers.
FDA authorizes Moderna COVID-19 vaccine for emergency use
By Matthew Perrone and Lauran Neergaard
Published
FDA advisory committee votes to recommend emergency use of Moderna COVID-19 vaccine
A key advisory committee to the FDA on Thursday voted to recommend the approval of Moderna’s COVID-19 vaccine for emergency use, one of the final hurdles before FDA authorization.
WASHINGTON - The U.S. Food and Drug Administration authorized Moderna’s coronavirus vaccine for emergency use on Friday, the second vaccine to be approved by U.S. regulators to prevent severe COVID-19 illness.
FDA Commissioner Stephen M. Hahn, called the approval another crucial step in the fight against this global pandemic.
1 of 2 FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Thursday, Dec. 17, 2020, a panel of independent experts is meeting to discuss a vaccine made by Moderna. The panel s review for the Food and Drug Administration is the next-to-last step before the agency decides whether the shots can be used on an emergency basis. (AP Photo/Hans Pennink)
2 of 2 FILE - A man stands outside an entrance to a Moderna, Inc., building, Monday, May 18, 2020, in Cambridge, Mass. A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday, Dec. 17, 2020 as government experts convened for a final public review of its safety and effectiveness. The shot from Moderna and the National Institutes of Health is urgently needed as the country continues to record ever-higher numbers